Category: Diseases & Conditions
Diseases & Conditions market research reports by GlobalData
-
Thematic Intelligence - Biosimilars in oncology
Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More
-
Gout - Opportunity Assessment and Forecast
Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ... Read More
-
Hepatitis B - Global Clinical Trials Review, 2023
Hepatitis B - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatitis B Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ... Read More
-
Osteoporosis - Global Clinical Trials Review, 2023
Osteoporosis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Osteoporosis Clinical trials scenario. This report provides top line da ... Read More
-
Insomnia - Opportunity Assessment and Forecast
Insomnia - Opportunity Assessment and Forecast Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the insomnia market through 2032. Insomnia, currently represented in the International Classification of Sleep Disorders (Th ... Read More
-
Gaucher Disease - Opportunity Assessment and Forecast
Gaucher Disease - Opportunity Assessment and Forecast Summary The prevalence of GD is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 0.39%. Currently, the marketed treatment regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elel ... Read More
-
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regul ... Read More
-
Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulator ... Read More
-
Generalized Pustular Psoriasis (GPP) - Competitive Landscape
Generalized Pustular Psoriasis (GPP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GPP therapeutics. More than 21,700 diagnosed prevalent cases of GPP are anticipated in 2023 in the 16 countries covered in GlobalData’s ... Read More
-
Anal Cancer (AC) - Competitive Landscape
Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More
-
Digital Marketing Trends in Non-small Cell Lung Cancer
Digital Marketing Trends in Non-small Cell Lung Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across non-small cell lung cancer (NSCLC) patient sites in the US, with over 2.4 million visitors from October 2022 to September 2023. This was followed by BMS's Opdivo.com (1.7 mil ... Read More
-
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory ... Read More
-
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 ... Read More
-
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. GlobalData's Medical Devices sector report, “Dry Powder Inhaler Devices Pipeline Report in ... Read More
-
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More
-
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Seasonal Influenza Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, ... Read More
-
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, E ... Read More
-
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More
-
Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Infusion Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update pr ... Read More
-
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary The report provides an in-depth assessment of the Myasthenia gravis market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More
Research Assistance
